PMR-116

N/A

Report date: 2024/01/05 17:56:00
NME

Base Information

Drug NamePMR-116
Drug Alias NamePMR-116
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA polymerase I inhibitors
TargetsRNA polymerase I
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPimera Inc
China Registration ClassN/A

Develop Information

Active CompaniesPimera Australia Pty LtdPimera Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A